Nobody likes to be given a grade of F in school…or in stock ratings. Yet, these stocks have shown such poor price action recently that they have fallen to this lowly state of a POWR Rating of “F” Strong Sell.

Aphria is the most well known of the companies found on this list. This once high flying medical marijuana stock has tumbled of late. BelGene, Hecla and Mallinckrodt and Malink are other notable additions. Check out the full list of upgrades below.

Symbol/NamePricePOWR Rating
AMCN
AirMedia Group Inc., each representing ten ordinary shares
1.85F
Strong Sell
APHA
Aphria Inc. Common Shares
7.65F
Strong Sell
BGNE
BeiGene, Ltd.
119.8F
Strong Sell
CDTX
Cidara Therapeutics, Inc.
2.38F
Strong Sell
EXTN
Exterran Corporation Common Stock
17.06F
Strong Sell
GSUM
Gridsum Holding Inc.
2.86F
Strong Sell
HL
Hecla Mining Company Common Stock
2.15F
Strong Sell
HOS
Hornbeck Offshore Services Common Stock
1.41F
Strong Sell
HX
Hexindai Inc. – ADR
2.79F
Strong Sell
KDMN
Kadmon Holdings, Inc. Common Stock
2.3F
Strong Sell
MGEN
Miragen Therapeutics, Inc.
2.73F
Strong Sell
MGNX
MacroGenics, Inc.
16.21F
Strong Sell
MNK
Mallinckrodt plc Ordinary Shares
18.23F
Strong Sell
NERV
Minerva Neurosciences, Inc
7.03F
Strong Sell

 

All of these stocks were recently downgraded to a POWR Rating of “F” Strong Sell. The POWR Ratings is a momentum based stock ranking system. In general, stocks don’t suffer this poor of price action unless the fundamental outlook has also become very weak.

Typically when both the fundamentals and price action head south…the stock continues to underperform into the future. The best strategy is to sell these shares and find better opportunities elsewhere. The place to look for greener pastures is our full list of ”A” rated Strong Buy stocks found here: https://stocknews.com/best-stocks/



About the Author: Steve Reitmeister


Steve is better known to the StockNews audience as “Reity”. Not only is he the CEO of the firm, but he also shares his 40 years of investment experience in the Reitmeister Total Return portfolio. Learn more about Reity’s background, along with links to his most recent articles and stock picks. More...